miR-145-mediated down-regulation of SENP1 induced quiescence of prostate cancer cells and reversed SENP1-promoted tumorigenesis in mice, pointing to miR-145 as a molecule of therapeutic value against cancer. Here, SENP1 is linked to prostate cancer.